Cyclosporine Therapeutic Cheat Sheet
701970197019
Welcome to the next delivery of our series, Therapeutic Cheat Sheet, wherein we take a deep dive into the literature and guidelines to give you a quick reference on the use of new or complex therapies. This series will become your go-to for information about dosing, potential interactions and laboratory monitoring, just to name a few. Next up: Cyclosporine.
Cyclosporine is a versatile and v …
Welcome to the next delivery of our series, Therapeutic Cheat Sheet, wherein we take a deep dive into the literature and guidelines to give you a quick reference on the use of new or complex therapies. This series will become your go-to for information about dosing, potential interactions and laboratory monitoring, just to name a few. Next up: Cyclosporine.
Cyclosporine is a versatile and v … 
What is the most likely diagnosis in this 16 year old patient who developed this generalized eruption 2 weeks after onset of sore throat due to strep infection?
A. Psoriasis
B. Pityriasis rosea
C. Cutaneous T-cell lymphoma
D. Contact dermatitis
E. Lichen planus
To find out the correct answer and read the explanation, click here.
Brought to you by our Brand Partner
… 
Derm In-Review Advisory Council Member, Dr. Ramya Kollipara, searched dermatology journals so that you don’t have to! She reports on important take-aways from different medical journals for the months of April, May, and June of 2018. Find study tools and more like this at Derm In-Review.
It is key to keep in mind that “important” is subjective and what is contained in this review is one … 
Below are the issue highlights and Editor Picks for the December issue of JDD!
JDD CONTINUING EDUCATION SUPPLEMENT: Issues and Considerations for Optimal Outcomes in Acne Management describes the role of retinoids in the management of acne and treatment and prevention strategies for hypertrophic and atrophic acne scarring in all skin types and identifies patient-specific issues impacting effe … 
JDD Podcast Recap and Author Interview
There has been vast growth in the array of treatment options for psoriasis over the last two decades. Not surprisingly, the variety of new drugs for this chronic condition has resulted in substantial direct-to-consumer marketing. However, patients with psoriasis are still largely undertreated. This discrepancy is explored in the paper “Discordance Be … 